APPH — Apontis Pharma AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapHigh Flyer

Annual balance sheet for Apontis Pharma AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	GAS	GAS	GAS	GAS	GAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	8.06	29.8	36.3	26.8	15.5
Net Total Accounts Receivable
Net Total Receivables	1.47	3.02	2.44	1.2	0.231
Total Inventory
Prepaid Expenses
Total Current Assets	12.9	38	42.4	35.1	22.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.041	0.019	0.045	0.03	0.018
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	29.7	54.1	59.9	57.5	44.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.31	3.68	5.96	11.3	5.12
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	26.2	13.4	18.3	27.2	13.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	3.46	40.7	41.6	30.3	31
Total Liabilities & Shareholders' Equity	29.7	54.1	59.9	57.5	44.4
Total Common Shares Outstanding